Anixa Biosciences Inc
ANIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000715446
In the last 90 days, Anixa Biosciences Inc insiders filed 15 open-market purchases and 0 sales; 63 institutions reported holding it in 13F filings for Q2 2026, worth $15.0M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Anixa Biosciences Inc changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 60 | 63 | +3 |
| Shares | 5.09M | 5.34M | +252.5K (+5.0%) |
| Value | $13.1M | $15.0M | +$1.82M (+13.9%) |
New holders (10)
Institutions that held Anixa Biosciences Inc at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Modern Wealth Management, LLC | 32,000 | $89.6K | 0.00% |
| Citadel Advisors LLC | 31,887 | $89.3K | 0.00% |
| Axq Capital, LP | 14,633 | $41.0K | 0.00% |
| Group One Trading, L.P. | 13,531 | $37.9K | 0.00% |
| Aptus Capital Advisors, LLC | 10,885 | $30.5K | 0.00% |
| Integrated Wealth Concepts LLC | 10,885 | $30.5K | 0.00% |
| Sanctuary Advisors, LLC | 10,450 | $29.3K | 0.00% |
| JPMorgan Chase & Co | 2,090 | $5.96K | 0.00% |
| Barclays PLC | 217 | $608 | 0.00% |
| SRS Capital Advisors, Inc. | 100 | $280 | 0.00% |
Sold out (7)
Institutions that held Anixa Biosciences Inc at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Susquehanna International Group, LLP | 99,468 | $256.6K |
| Point72 Asset Management, L.P. | 17,276 | $44.6K |
| Two Sigma Investments, LP | 14,492 | $37.4K |
| Acadian Asset Management LLC | 12,898 | $33.0K |
| Catalyst Funds Management Pty Ltd | 12,300 | $31.7K |
| MAI Capital Management | 3,000 | $7.74K |
| Advisory Services Network, LLC | 400 | $1.03K |